A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Ointment in Women with Cytological Abnormalities of the Uterine Cervix
This study is currently recruiting participants.
Primary Objective: This study aims to investigate efficacy, safety and tolerability of R131 vaginal ointment in women with low grade and high grade cervical intraepithelial neoplasia (CIN) who have been diagnosed with Human papilloma virus (HPV).
Principal Investigator: Amanda Tristram
Study Coordinator: Michelle Hennessy
Trial Website: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376148
This study is in start-up.
Principle Investigator: Amanda Tristram
Study Coordinator: Marina Dzhelali